Nancy Miller-Rich - Jun 8, 2021 Form 4 Insider Report for Aldeyra Therapeutics, Inc. (ALDX)

Role
Director
Signature
/s/ Nancy Miller-Rich
Stock symbol
ALDX
Transactions as of
Jun 8, 2021
Transactions value $
$0
Form type
4
Date filed
6/10/2021, 05:46 PM
Previous filing
Jun 1, 2021
Next filing
Nov 9, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALDX Stock Option (Right to Buy) Award $0 +13.5K $0.00 13.5K Jun 8, 2021 Common Stock 13.5K $12.97 Direct F1
transaction ALDX Stock Option (Right to Buy) Award $0 +583 $0.00 583 Jun 8, 2021 Common Stock 583 $12.97 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.
F2 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation Committee of the Board of Directors of the Issuer through the applicable vesting date.